LY2541546

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY2541546, covering 2017-12-04 to 2019-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2541546 in Healthy Postmenopausal Women [Phase 1]